NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/21/2024
Back to search
Official data from USPTO
NIKKEI BIOTECHNOLOGY & BUSINESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NIKKEI BIOTECHNOLOGY & BUSINESS
ST13
US500000076487188Class
16
Filing
76487188
Registration
2852834
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
05/21/2024
Trademark type
Word
Nice classes
16
Filing date
02/04/2003
Registration date
06/15/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/21/2024
Last transaction
05/21/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/22/2001
First use in commerce
05/15/2001
Drawing code
1
Owner type
03
Owner location
Minato-ku, Tokyo, JP
Examiner
WAHLBERG,STACY B
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Nikkei Business Publications, Inc.
Nikkei Business Publications, Inc.
Representatives
Jeffrey L. Thompson Thompson Law, P.A.
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Periodic publicationsmagazines and journals relating to the field of biotechnologybusiness and business management
Publications
History of USPTO decisions and trademark events.
21 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/21/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/20/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
02/06/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/15/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/02/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/02/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/02/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/02/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
12/10/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/07/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/30/2010
E815
TEAS SECTION 8 & 15 RECEIVED
06/14/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
06/15/2004
PUBO
PUBLISHED FOR OPPOSITION
03/23/2004
NPUB
NOTICE OF PUBLICATION
03/03/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/20/2004
CNEA
EXAMINERS AMENDMENT MAILED
01/15/2004
CNRT
NON-FINAL ACTION MAILED
08/07/2003
DOCK
ASSIGNED TO EXAMINER
07/24/2003
Continuous trademark protection
Get notified about every new filing that threatens NIKKEI BIOTECHNOLOGY & BUSINESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.